Clozaril Now Covered by National Health Insurance

Following the last year's approval by the Korea Food and Drug Administration (KFDA) on the additional indication of Clozaril (active ingredient: clozapine) to reduce risk of suicidal behavior in patients with schizophrenia or schizoaffective disorder, Clozaril is now included under the National Health Insurance (NHI) reimbursable items, effective January 1st.

According to Novartis Korea, the...